|
Pediatric Cancer Research
For almost 20 years, Golf Fights Cancer has focused its efforts on providing transformational support to underfunded critical needs within the cancer community. There is no better example of this than our investment in pediatric cancer research.
Considered a rare disease, 400,000 children and adolescents worldwide are diagnosed each year. In the U.S., cancer kills approximately 1,800 young people annually, more than all other diseases combined. Yet, since 1978, less than 12 childhood cancer drugs have earned FDA approval. For comparison purposes, an average of 12 drugs for 'adult cancers' will reach the market annually. Most distressing, 1 in 5 children with cancer has an incurable form that 40 years of ongoing research has yet to resolve.
Compelled by these sobering statistics and inspired by the desperate families fighting for a cure, Golf Fights Cancer has allocated more than $1.7 Million towards innovative research targeting childhood cancers that have the most dire outcomes. Our investments include:
-
Beat Childhood Cancer: Funding the Precision Medicine Program targeting children who have run out of treatment options and/or whose relapsed disease is not responding to treatment
-
Boston Children's Hospital: Funding the Pediatric Cancer Vulnerability Project in honor of Kiley Sullivan
-
Children's Cancer Therapy Development Institute: Funding DIPG research in memory of Danny Nickerson, Ewing's Sarcoma research in memory of Pete Fox, and Rhabdomyosarcoma research in honor of Kiley Sullivan
-
Children's Hospital of Pittsburgh: Funding for DIPG research in memory of Ellie Kavalieros
-
Dana-Farber Cancer Institute: Funding DIPG research in memory of Ellie Kavalieros
| 
